For more information or confidential assistance
Call 800-306-3180

Bellwether Cases Chosen in Xarelto MDL

Xarelto packaging
Multidistrict (MDL) litigation established in order to consolidate all federal cases related to Xarelto has now progressed to the point where U.S. District Judge Eldon Fallon has chosen a series of four representative cases which will be heard in early 2017. The purpose of these... Read More

Safety Study for Xarelto Under Question by FDA

Since it first hit the market in 2011, millions of Americans have been prescribed Xarelto, a newer generation of blood-thinning drugs touted as an alternative to warfarin (Coumadin). But recently, healthcare experts have been questioning whether the clinical trial that led to the FDA approval... Read More

Xarelto MDL Bellwether Selection Underway

The process for determining which cases from the Xarelto multidistrict litigation in the Eastern District of Louisiana will be included in a bellwether discovery pool has been determined. U.S. District Judge Eldon Fallon issued a case management order on Nov. 20 outlining the selection criteria.... Read More

Four Plaintiffs File Joint Complaint in Xarelto MDL

Adding to the growing list of lawsuits in the Xarelto federal multidistrict litigation (MDL), a group of four plaintiffs have come together to file a joint complaint alleging that they each suffered serious harm after using Jannsen's anticoagulant drug. The highly detailed complaint outlines the... Read More

Xarelto Cases to be Selected for Bellwether Trials

Beginning shortly after its introduction in 2011, a number of plaintiffs have come forward alleging severe – and sometimes deadly – side effects with the anti-coagulant drug Xarelto. The drug, which was introduced to the market as a more convenient alternative to the traditional warfarin,... Read More